547 related articles for article (PubMed ID: 16001399)
41. Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice.
Lee J; Chae K; Ha J; Park BY; Lee HS; Jeong S; Kim MY; Yoon M
J Ethnopharmacol; 2008 Jan; 115(2):263-70. PubMed ID: 18023310
[TBL] [Abstract][Full Text] [Related]
42. Antisense inhibition of S6 kinase 1 produces improved glucose tolerance and is well tolerated for 4 weeks of treatment in rats.
Younis HS; Hirakawa B; Scott W; Tran P; Bhat G; Affolter T; Chapman J; Heyen J; Chakravarty K; Alton G
Pharmacology; 2011; 87(1-2):11-23. PubMed ID: 21178385
[TBL] [Abstract][Full Text] [Related]
43. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
Thupari JN; Kim EK; Moran TH; Ronnett GV; Kuhajda FP
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E97-E104. PubMed ID: 14736702
[TBL] [Abstract][Full Text] [Related]
44. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice.
Fromenty B; Vadrot N; Massart J; Turlin B; Barri-Ova N; Lettéron P; Fautrel A; Robin MA
J Pharmacol Exp Ther; 2009 Oct; 331(1):23-34. PubMed ID: 19587315
[TBL] [Abstract][Full Text] [Related]
45. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
Orellana-Gavaldà JM; Herrero L; Malandrino MI; Pañeda A; Sol Rodríguez-Peña M; Petry H; Asins G; Van Deventer S; Hegardt FG; Serra D
Hepatology; 2011 Mar; 53(3):821-32. PubMed ID: 21319201
[TBL] [Abstract][Full Text] [Related]
46. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism.
Watts LM; Manchem VP; Leedom TA; Rivard AL; McKay RA; Bao D; Neroladakis T; Monia BP; Bodenmiller DM; Cao JX; Zhang HY; Cox AL; Jacobs SJ; Michael MD; Sloop KW; Bhanot S
Diabetes; 2005 Jun; 54(6):1846-53. PubMed ID: 15919808
[TBL] [Abstract][Full Text] [Related]
47. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
[TBL] [Abstract][Full Text] [Related]
48. Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha.
Huang TH; Peng G; Li GQ; Yamahara J; Roufogalis BD; Li Y
Toxicol Appl Pharmacol; 2006 Feb; 210(3):225-35. PubMed ID: 15975614
[TBL] [Abstract][Full Text] [Related]
49. Concerted elevation of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin.
Meegalla RL; Billheimer JT; Cheng D
Biochem Biophys Res Commun; 2002 Nov; 298(3):317-23. PubMed ID: 12413942
[TBL] [Abstract][Full Text] [Related]
50. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production.
Grefhorst A; Hoekstra J; Derks TG; Ouwens DM; Baller JF; Havinga R; Havekes LM; Romijn JA; Kuipers F
Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G592-8. PubMed ID: 15817811
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
[TBL] [Abstract][Full Text] [Related]
52. Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Shen KP; Lin HL; Hsieh SL; Kwan AL; Chen IJ; Wu BN
J Pharm Pharmacol; 2009 Apr; 61(4):517-25. PubMed ID: 19298700
[TBL] [Abstract][Full Text] [Related]
53. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
Matsusue K; Haluzik M; Lambert G; Yim SH; Gavrilova O; Ward JM; Brewer B; Reitman ML; Gonzalez FJ
J Clin Invest; 2003 Mar; 111(5):737-47. PubMed ID: 12618528
[TBL] [Abstract][Full Text] [Related]
54. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
[TBL] [Abstract][Full Text] [Related]
55. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
56. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
57. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
Raju J; Bird RP
Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
[TBL] [Abstract][Full Text] [Related]
58. The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2.
Qi J; Lang W; Geisler JG; Wang P; Petrounia I; Mai S; Smith C; Askari H; Struble GT; Williams R; Bhanot S; Monia BP; Bayoumy S; Grant E; Caldwell GW; Todd MJ; Liang Y; Gaul MD; Demarest KT; Connelly MA
J Lipid Res; 2012 Jun; 53(6):1106-16. PubMed ID: 22493088
[TBL] [Abstract][Full Text] [Related]
59. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation.
Li JZ; Ye J; Xue B; Qi J; Zhang J; Zhou Z; Li Q; Wen Z; Li P
Diabetes; 2007 Oct; 56(10):2523-32. PubMed ID: 17646209
[TBL] [Abstract][Full Text] [Related]
60. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
